Life sciences · Interventional Study
ClinicalTrials.gov · October 9, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Interventional Study.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT07869355). This is a study registration, not published results. Lead sponsor: University of Illinois at Chicago. Recruitment status: NOT_YET_RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 30 participants (ESTIMATED). Conditions: Dietary Assessment, Dietary and Lifestyle Behaviour Change, Dietary Behavior, Metabolic Health, Obesity, Lifestyle Modification, Metabolic Syndrome Risk. Interventions: DIETARY_SUPPLEMENT: Explore the effect of MedDiet vs. Usual Diet on Fatty Acid Profile; DIAGNOSTIC_TEST: Explore the effect of MedDiet vs. Usual Diet on Breast Tumor Tissue; DIAGNOSTIC_TEST: Explore the effect of MedDiet vs. Usual Diet on Lipids; DIAGNOSTIC_TEST: Explore the effect of MedDiet vs. Usual Diet on tumor tissue expression. Primary outcome measures: Aim 1a , 3 weeks; Aim 1b , 3 weeks; Aim 1c , 3 weeks; Aim 2a , 3 weeks; Aim 2b , 3 weeks; Aim 2c , 3 weeks; Aim 2d , 3 weeks; Aim 2e , 3 weeks. Brief summary: Explore the effect of MedDiet vs. Usual Diet on circulating and breast tumor fatty acid profiles. The investigators aim to examine impact on tumor biology in newly diagnosed participants.